Evidence map›Paper›PMID 34432291›Full record

ArticleJournal of surgical oncology2021

Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study.

Umberto Bracale, Francesco Corcione, Giusto Pignata, Jacopo Andreuccetti, Pasquale Dolce, Luigi Boni, Elisa Cassinotti, Stefano Olmi, Matteo Uccelli, Monica Gualtierotti and 8 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Robotic gastrectomy for gastric cancer: systematic review and future directions.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Umberto BracaleDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Francesco CorcioneDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Giusto PignataDepartment of General Surgery II, Spedali Civili of Brescia, Brescia, Italy.
Jacopo AndreuccettiDepartment of General and Mininvasive surgery, San Camillo Hospital, Trento, Italy.
Pasquale DolceDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Luigi BoniDepartment of Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University, Milano, Italy.
Elisa CassinottiDepartment of Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University, Milano, Italy.
Stefano OlmiDepartment of General and Oncologic Surgery, San Marco Hospital GSD, Zingonia, Italy.
Matteo UccelliDepartment of General and Oncologic Surgery, San Marco Hospital GSD, Zingonia, Italy.ORCID http://orcid.org/0000-0002-6056-1761
Monica GualtierottiDepartment of Minimally Invasive Oncologic Surgery, Niguarda Hospital, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Giovanni FerrariDepartment of Minimally Invasive Oncologic Surgery, Niguarda Hospital, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Paolo De MartiniDepartment of Minimally Invasive Oncologic Surgery, Niguarda Hospital, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Miloš BjelovićDepartment of Minimally Invasive Upper Digestive Surgery, Hospital for Digestive Surgery, Clinical Center of Serbia, Belgrade, Serbia.
Dragan GunjićDepartment of Minimally Invasive Upper Digestive Surgery, Hospital for Digestive Surgery, Clinical Center of Serbia, Belgrade, Serbia.
Diego CuccurulloDepartment of General, Mini-Invasive and Robotic Surgery, Monaldi Hospital, Naples, Italy.
Antonio SciutoDepartment of General Surgery, Santa Maria delle Grazie Hospital, Pozzuoli, Naples, Italy.
Felice PirozziDepartment of General Surgery, Santa Maria delle Grazie Hospital, Pozzuoli, Naples, Italy.
Roberto PeltriniDepartment of Public Health, University of Naples Federico II, Naples, Italy.ORCID http://orcid.org/0000-0003-0445-2269
University of Naples Federico II · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCenter for Health, Exercise and Sport Sciences · RSFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITOspedale Santa Maria · ITVeterinary Oncological Center · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITIRCCS San Camillo Hospital · ITOspedale Monaldi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesIn the setting of a minimally invasive approach, we aimed to compare short and long-term postoperative outcomes of patients treated with neoadjuvant therapy (NAT) + surgery or upfront surgery in Western population.

methodsAll consecutive patients from six Italian and one Serbian center with locally advanced gastric cancer who had undergone laparoscopic gastrectomy with D2 lymph node dissection were selected between 2005 and 2019. After propensity score-matching, postoperative morbidity and oncologic outcomes were investigated.

resultsAfter matching, 97 patients were allocated in each cohort with a mean age of 69.4 and 70.5 years. The two groups showed no difference in operative details except for a higher conversion rate in the NAT group (p = 0.038). The overall postoperative complications rate significantly differed between NAT + surgery (38.1%) and US (21.6%) group (p = 0.019). NAT was found to be related to a higher risk of postoperative morbidity in patients older than 60 years old (p = 0.013) but not in patients younger (p = 0.620). Conversely, no difference in overall survival (p = 0.41) and disease-free-survival (p = 0.34) was found between groups.

conclusionsNAT appears to be related to a higher postoperative complication rate and equivalent oncological outcomes when compared with surgery alone. However, poor short-term outcomes are more evident in patients over 60 years old receiving NAT.

Indexed as

AgedAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyFemaleFollow-Up StudiesGastrectomyHumansLaparoscopyLength of StayMaleMiddle AgedNeoadjuvant TherapyPostoperative PeriodPrognosisRetrospective StudiesStomach Neoplasmsgastric cancerlaparoscopic gastrectomyneoadjuvant therapyoncological outcomespostoparative complications

Identifiers

PMID34432291
PMCPMC9291045
OpenAlexW3195655629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.